Related Experiment Video
Updated: Aug 10, 2025

05:44
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
1.5K
Stress-Induced Transcriptomic Changes in Females with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Reveal
Derek J Van Booven1, Jackson Gamer2,3, Andrew Joseph2,3
1John P. Hussman Institute for Human Genomics, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
International Journal of Molecular Sciences
|February 11, 2023
Summary
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) involves debilitating fatigue. This study found ME/CFS patients exhibit immune dysregulation and cellular stress during recovery after exercise, unlike healthy controls.
Area of Science:
- Immunology
- Genomics
- Neuroscience
Background:
- Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex, multi-organ illness.
- Key symptoms include debilitating fatigue and post-exertional malaise (PEM).
Purpose of the Study:
- To investigate transcriptomic changes in female ME/CFS patients during an exercise challenge.
- To compare gene expression responses between ME/CFS patients and healthy controls (HCs).
Main Methods:
- Collected blood samples at baseline, maximal exertion, and post-exercise recovery.
- Performed transcriptomic analysis to evaluate gene expression patterns.
- Utilized a controlled exercise challenge to induce PEM.
Main Results:
- ME/CFS patients showed no significant gene expression changes during maximal exertion.
- Healthy controls exhibited altered immune cell signaling networks during exertion.
- During recovery, ME/CFS patients displayed dysregulated immune signaling and cellular stress responses.
Conclusions:
- Exercise challenge reveals distinct transcriptomic responses in ME/CFS patients during recovery.
- Identified unique immune and cellular pathways offer targets for ME/CFS research and treatment.
- Findings highlight immune dysregulation as a key feature of ME/CFS pathophysiology.

